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Background
The high prevalence and incidence of prostate cancer is a
global phenomenon [1,2]. In the pre-Prostate Specific
Antigen (PSA) era, the clinical hallmarks of prostate can-
cer were late disease presentations and high mortality
rates [3]. The documentation of even more advanced pres-
entations and higher mortality rates in males of African
ancestry is of great concern for countries like the Bahamas
with significant populations of this ethnicity. [4-10]
Over the past 15 years, there has been has been a notable
change in the clinical presentation of prostate cancer, with
more organ confined disease [11,12]. Studies suggest that
this documented and consistent trend in the developed
countries [13-17], of early disease detection and down
stage migration with associated decreasing mortalities,
reflect the merits of aggressive PSA screening programs.
In the Bahamas, a country where 85% of the population
are of African ancestry, prostate cancer represents both the
highest incidences of male malignancy occurrences and
cancer specific deaths. Unfortunately, despite the
increased campaigns for early detection since the intro-
duction of PSA testing, there has been no down stage
migration of clinical presentations of this malignancy in
the Bahamas, as has occurred in the developed countries
[18]. The cultural ethos of the Caribbean male of African
ancestry suggests that health preventative initiatives,
inclusive of the digital rectal examination are counter to
our valued macho-male image. Men therefore do not avail
themselves of the publically accessible early prostate can-
cer detection programs.
With this high incidence of advance disease and noting
that hormonal therapy remains the first treatment of
choice, we sought to determine the most common treat-
ment modality employed in our institution with regards
to surgical versus medical castration. Emphasizing the
need for cost effective and affordable care in our develop-
ing country, would men of African ancestry in a macho
dominated society opt to have surgical castration as the
preferred treatment?
Methods
All men presenting with advanced prostate cancer at the
government-owned public health facility, the Princess
Margaret Hospital, are informed by the Consultant Uro-
logical Surgeon of the various medical and surgical hor-
monal options and their advantages and disadvantages.
They are informed also that the institution would provide
the surgical option of bilateral orchiectomies at no charge,
but the cost of the medical treatment option must be
borne by the patient.
At the only two hospitals on New Providence Island in the
Bahamas, the Princess Margaret Hospital, (450 beds) and
the privately-owned Doctors Hospital (70 beds), all
pathology reports for biopsy proven cancers and the oper-
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ative log for the number of surgical castration procedures
were reviewed during a thirteen years period from 1987 to
2000. The data base is compiled from that of a solo urol-
ogy service providing care in both the private and public
sectors in the Bahamas; this service represents 70% of the
urological health care delivered in the country. It is impor-
tant to note that almost 70% of the population of the
Bahamas resides on New Providence Island on which the
capital city of the Bahamas is located.
Results
There were 535 pathology-diagnosed cases of prostate
cancer identified. 275 bilateral orchiectomies were per-
formed in patients presenting with advance prostate can-
cer during this period, an average of 21.5 bilateral
orchiectomies performed annually.
For the five years period 2003 to 2007 at the government's
public hospital, all cases of pathology proven prostate
cancer were reviewed. There were 363 documented cases
of prostate cancer. During this period, there were 103
cases of bilateral orchiectomies recorded in the operative
log of the hospital, averaging 20.6 cases per year. The fre-
quency of bilateral orchiectomies performed annually was
similar to that of the thirteen year period.
This high rate of hormonal treatment is an indication of
the continuing trends of advance disease as the initial
presentation of males diagnosed with prostate cancer in
the Bahamas. The trend of increasing annual mortality
rates for prostate cancer has continued unabated for the
past 15 years, contrary to that of the developed countries;
this is well documented in the annual cancer mortality
reports by the Health Information and Research Unit of
the Ministry of Health and Social Services of the Bahamas.
Conclusion
This study concludes that men in the Bahamas with
advanced prostate cancer would opt for surgical castration
when presented 'positively' as the preferred treatment.
These findings are contrary to the perception of the
macho-male image of the Caribbean male and invite fur-
ther studies into the complex psyche of our Bahamian
males.
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